From Hypertension to Heart Failure:
Arterial hypertension, coronary heart disease and heart fail ure are the commonest cardiovascular conditions to present in clinical practice. Over the past few years it has become in creasingly clear that they are closely and causally interrelated and that their relationship can have a significant...
Gespeichert in:
| Weitere Verfasser: | , , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Berlin, Heidelberg
Springer Berlin Heidelberg
1998
|
| Schlagworte: | |
| Online-Zugang: | UBR01 URL des Erstveröffentlichers |
| Zusammenfassung: | Arterial hypertension, coronary heart disease and heart fail ure are the commonest cardiovascular conditions to present in clinical practice. Over the past few years it has become in creasingly clear that they are closely and causally interrelated and that their relationship can have a significant bearing on prognosis. Epidemiological studies have shown that arterial hypertension is one of the most important risk factors for de veloping heart failure. Only one in four patients with hyper tension is adequately managed, and in 50% of cases, the hypertension has not been recognised or treated. Patients with pre-existing hypertension who go on to suffer an acute myocardial infarction have usually not previously had typi cal angina symptoms, the infarct territory is larger, life threatening arrhythmias are commoner and hence in-hospi tal mortality and long-term prognosis are markedly worse. The presence of raised blood pressure in the post-infarct phase doubles the risk of manifest heart failure. The close relationship between hypertension, coronary heart disease and heart failure makes the choice of therapeu tic strategy particularly important. Agents and classes of agents that have prognostic value in all three conditions should be considered first, as synergy might result in addi tional benefits. In such patients, this sort of therapeutic deci sion-making might have further advantages. The use of these agents may prevent complications which are not yet clinically obvious (such as heart failure) |
| Beschreibung: | 1 Online-Ressource (XIII, 258 p. 32 illus) |
| ISBN: | 9783642603006 |
| DOI: | 10.1007/978-3-642-60300-6 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV046144336 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 190905s1998 |||| o||u| ||||||eng d | ||
| 020 | |a 9783642603006 |9 978-3-642-60300-6 | ||
| 024 | 7 | |a 10.1007/978-3-642-60300-6 |2 doi | |
| 035 | |a (ZDB-2-SME)978-3-642-60300-6 | ||
| 035 | |a (OCoLC)1119009745 | ||
| 035 | |a (DE-599)BVBBV046144336 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 | ||
| 082 | 0 | |a 616.12 |2 23 | |
| 084 | |a XI 4400 |0 (DE-625)153006:12905 |2 rvk | ||
| 245 | 1 | 0 | |a From Hypertension to Heart Failure |c edited by Michael Böhm, John H. Laragh, Manfred Zehender |
| 264 | 1 | |a Berlin, Heidelberg |b Springer Berlin Heidelberg |c 1998 | |
| 300 | |a 1 Online-Ressource (XIII, 258 p. 32 illus) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 520 | |a Arterial hypertension, coronary heart disease and heart fail ure are the commonest cardiovascular conditions to present in clinical practice. Over the past few years it has become in creasingly clear that they are closely and causally interrelated and that their relationship can have a significant bearing on prognosis. Epidemiological studies have shown that arterial hypertension is one of the most important risk factors for de veloping heart failure. Only one in four patients with hyper tension is adequately managed, and in 50% of cases, the hypertension has not been recognised or treated. Patients with pre-existing hypertension who go on to suffer an acute myocardial infarction have usually not previously had typi cal angina symptoms, the infarct territory is larger, life threatening arrhythmias are commoner and hence in-hospi tal mortality and long-term prognosis are markedly worse. The presence of raised blood pressure in the post-infarct phase doubles the risk of manifest heart failure. The close relationship between hypertension, coronary heart disease and heart failure makes the choice of therapeu tic strategy particularly important. Agents and classes of agents that have prognostic value in all three conditions should be considered first, as synergy might result in addi tional benefits. In such patients, this sort of therapeutic deci sion-making might have further advantages. The use of these agents may prevent complications which are not yet clinically obvious (such as heart failure) | ||
| 650 | 4 | |a Cardiology | |
| 650 | 4 | |a Cardiology | |
| 650 | 0 | 7 | |a Angina pectoris |0 (DE-588)4002029-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Hypertonie |0 (DE-588)4026372-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Beta-Blocker |0 (DE-588)4006088-3 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Herzinsuffizienz |0 (DE-588)4024655-3 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
| 689 | 0 | 0 | |a Hypertonie |0 (DE-588)4026372-1 |D s |
| 689 | 0 | 1 | |a Beta-Blocker |0 (DE-588)4006088-3 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Herzinsuffizienz |0 (DE-588)4024655-3 |D s |
| 689 | 1 | 1 | |a Beta-Blocker |0 (DE-588)4006088-3 |D s |
| 689 | 1 | |5 DE-604 | |
| 689 | 2 | 0 | |a Angina pectoris |0 (DE-588)4002029-0 |D s |
| 689 | 2 | 1 | |a Beta-Blocker |0 (DE-588)4006088-3 |D s |
| 689 | 2 | |5 DE-604 | |
| 700 | 1 | |a Böhm, Michael |4 edt | |
| 700 | 1 | |a Laragh, John H. |4 edt | |
| 700 | 1 | |a Zehender, Manfred |4 edt | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783540635420 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783642603013 |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-3-642-60300-6 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-2-SME | ||
| 940 | 1 | |q ZDB-2-SME_1990/2004 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-031524521 | ||
| 966 | e | |u https://doi.org/10.1007/978-3-642-60300-6 |l UBR01 |p ZDB-2-SME |q ZDB-2-SME_1990/2004 |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804180479599968256 |
|---|---|
| any_adam_object | |
| author2 | Böhm, Michael Laragh, John H. Zehender, Manfred |
| author2_role | edt edt edt |
| author2_variant | m b mb j h l jh jhl m z mz |
| author_facet | Böhm, Michael Laragh, John H. Zehender, Manfred |
| building | Verbundindex |
| bvnumber | BV046144336 |
| classification_rvk | XI 4400 |
| collection | ZDB-2-SME |
| ctrlnum | (ZDB-2-SME)978-3-642-60300-6 (OCoLC)1119009745 (DE-599)BVBBV046144336 |
| dewey-full | 616.12 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.12 |
| dewey-search | 616.12 |
| dewey-sort | 3616.12 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| doi_str_mv | 10.1007/978-3-642-60300-6 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03762nmm a2200601zc 4500</leader><controlfield tag="001">BV046144336</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">190905s1998 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783642603006</subfield><subfield code="9">978-3-642-60300-6</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-3-642-60300-6</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-SME)978-3-642-60300-6</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1119009745</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV046144336</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.12</subfield><subfield code="2">23</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XI 4400</subfield><subfield code="0">(DE-625)153006:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">From Hypertension to Heart Failure</subfield><subfield code="c">edited by Michael Böhm, John H. Laragh, Manfred Zehender</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Berlin, Heidelberg</subfield><subfield code="b">Springer Berlin Heidelberg</subfield><subfield code="c">1998</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (XIII, 258 p. 32 illus)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Arterial hypertension, coronary heart disease and heart fail ure are the commonest cardiovascular conditions to present in clinical practice. Over the past few years it has become in creasingly clear that they are closely and causally interrelated and that their relationship can have a significant bearing on prognosis. Epidemiological studies have shown that arterial hypertension is one of the most important risk factors for de veloping heart failure. Only one in four patients with hyper tension is adequately managed, and in 50% of cases, the hypertension has not been recognised or treated. Patients with pre-existing hypertension who go on to suffer an acute myocardial infarction have usually not previously had typi cal angina symptoms, the infarct territory is larger, life threatening arrhythmias are commoner and hence in-hospi tal mortality and long-term prognosis are markedly worse. The presence of raised blood pressure in the post-infarct phase doubles the risk of manifest heart failure. The close relationship between hypertension, coronary heart disease and heart failure makes the choice of therapeu tic strategy particularly important. Agents and classes of agents that have prognostic value in all three conditions should be considered first, as synergy might result in addi tional benefits. In such patients, this sort of therapeutic deci sion-making might have further advantages. The use of these agents may prevent complications which are not yet clinically obvious (such as heart failure)</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cardiology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cardiology</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Angina pectoris</subfield><subfield code="0">(DE-588)4002029-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Hypertonie</subfield><subfield code="0">(DE-588)4026372-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Beta-Blocker</subfield><subfield code="0">(DE-588)4006088-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Herzinsuffizienz</subfield><subfield code="0">(DE-588)4024655-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Hypertonie</subfield><subfield code="0">(DE-588)4026372-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Beta-Blocker</subfield><subfield code="0">(DE-588)4006088-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Herzinsuffizienz</subfield><subfield code="0">(DE-588)4024655-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Beta-Blocker</subfield><subfield code="0">(DE-588)4006088-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Angina pectoris</subfield><subfield code="0">(DE-588)4002029-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="1"><subfield code="a">Beta-Blocker</subfield><subfield code="0">(DE-588)4006088-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Böhm, Michael</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Laragh, John H.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zehender, Manfred</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9783540635420</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9783642603013</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-3-642-60300-6</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SME</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-2-SME_1990/2004</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-031524521</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-3-642-60300-6</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-2-SME</subfield><subfield code="q">ZDB-2-SME_1990/2004</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content |
| genre_facet | Aufsatzsammlung |
| id | DE-604.BV046144336 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T08:36:25Z |
| institution | BVB |
| isbn | 9783642603006 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-031524521 |
| oclc_num | 1119009745 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR |
| owner_facet | DE-355 DE-BY-UBR |
| physical | 1 Online-Ressource (XIII, 258 p. 32 illus) |
| psigel | ZDB-2-SME ZDB-2-SME_1990/2004 ZDB-2-SME ZDB-2-SME_1990/2004 |
| publishDate | 1998 |
| publishDateSearch | 1998 |
| publishDateSort | 1998 |
| publisher | Springer Berlin Heidelberg |
| record_format | marc |
| spelling | From Hypertension to Heart Failure edited by Michael Böhm, John H. Laragh, Manfred Zehender Berlin, Heidelberg Springer Berlin Heidelberg 1998 1 Online-Ressource (XIII, 258 p. 32 illus) txt rdacontent c rdamedia cr rdacarrier Arterial hypertension, coronary heart disease and heart fail ure are the commonest cardiovascular conditions to present in clinical practice. Over the past few years it has become in creasingly clear that they are closely and causally interrelated and that their relationship can have a significant bearing on prognosis. Epidemiological studies have shown that arterial hypertension is one of the most important risk factors for de veloping heart failure. Only one in four patients with hyper tension is adequately managed, and in 50% of cases, the hypertension has not been recognised or treated. Patients with pre-existing hypertension who go on to suffer an acute myocardial infarction have usually not previously had typi cal angina symptoms, the infarct territory is larger, life threatening arrhythmias are commoner and hence in-hospi tal mortality and long-term prognosis are markedly worse. The presence of raised blood pressure in the post-infarct phase doubles the risk of manifest heart failure. The close relationship between hypertension, coronary heart disease and heart failure makes the choice of therapeu tic strategy particularly important. Agents and classes of agents that have prognostic value in all three conditions should be considered first, as synergy might result in addi tional benefits. In such patients, this sort of therapeutic deci sion-making might have further advantages. The use of these agents may prevent complications which are not yet clinically obvious (such as heart failure) Cardiology Angina pectoris (DE-588)4002029-0 gnd rswk-swf Hypertonie (DE-588)4026372-1 gnd rswk-swf Beta-Blocker (DE-588)4006088-3 gnd rswk-swf Herzinsuffizienz (DE-588)4024655-3 gnd rswk-swf (DE-588)4143413-4 Aufsatzsammlung gnd-content Hypertonie (DE-588)4026372-1 s Beta-Blocker (DE-588)4006088-3 s DE-604 Herzinsuffizienz (DE-588)4024655-3 s Angina pectoris (DE-588)4002029-0 s Böhm, Michael edt Laragh, John H. edt Zehender, Manfred edt Erscheint auch als Druck-Ausgabe 9783540635420 Erscheint auch als Druck-Ausgabe 9783642603013 https://doi.org/10.1007/978-3-642-60300-6 Verlag URL des Erstveröffentlichers Volltext |
| spellingShingle | From Hypertension to Heart Failure Cardiology Angina pectoris (DE-588)4002029-0 gnd Hypertonie (DE-588)4026372-1 gnd Beta-Blocker (DE-588)4006088-3 gnd Herzinsuffizienz (DE-588)4024655-3 gnd |
| subject_GND | (DE-588)4002029-0 (DE-588)4026372-1 (DE-588)4006088-3 (DE-588)4024655-3 (DE-588)4143413-4 |
| title | From Hypertension to Heart Failure |
| title_auth | From Hypertension to Heart Failure |
| title_exact_search | From Hypertension to Heart Failure |
| title_full | From Hypertension to Heart Failure edited by Michael Böhm, John H. Laragh, Manfred Zehender |
| title_fullStr | From Hypertension to Heart Failure edited by Michael Böhm, John H. Laragh, Manfred Zehender |
| title_full_unstemmed | From Hypertension to Heart Failure edited by Michael Böhm, John H. Laragh, Manfred Zehender |
| title_short | From Hypertension to Heart Failure |
| title_sort | from hypertension to heart failure |
| topic | Cardiology Angina pectoris (DE-588)4002029-0 gnd Hypertonie (DE-588)4026372-1 gnd Beta-Blocker (DE-588)4006088-3 gnd Herzinsuffizienz (DE-588)4024655-3 gnd |
| topic_facet | Cardiology Angina pectoris Hypertonie Beta-Blocker Herzinsuffizienz Aufsatzsammlung |
| url | https://doi.org/10.1007/978-3-642-60300-6 |
| work_keys_str_mv | AT bohmmichael fromhypertensiontoheartfailure AT laraghjohnh fromhypertensiontoheartfailure AT zehendermanfred fromhypertensiontoheartfailure |